Leonard Frank X

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
29
Insider Sells Sum
$8.4M

Insider Activity of Leonard Frank X

According to the SEC Form 4 filings, Leonard Frank X, being in a position of

  1. EVP, Pres., Novocure Oncology at NovoCure Limited,
    оver the last 12 months, has bought 0 shares, and sold 4597 shares for $73,902,
    over all time since 2021-03-02, has bought 0 shares, and sold 101659 shares for $8.4M.

The largest sale of all time was on 2023-01-05 and amounted to 10471 share of NovoCure Limited for $1.25M.

Biography of Leonard Frank X

No biography is available at this moment.

2024-03-04SaleNovoCure Limited
NVCR
EVP, Pres., Novocure Oncology
840
0.0008%
$16.01$13,448+6.21%
2024-03-01SaleNovoCure Limited
NVCR
EVP, Pres., Novocure Oncology
1,679
0.0015%
$16.03$26,909+7.02%
2024-02-28SaleNovoCure Limited
NVCR
EVP, Pres., Novocure Oncology
2,078
0.002%
$16.14$33,545+8.15%
2023-03-07SaleNovoCure Limited
NVCR
President, CNS Cancers US
8,318
0.0079%
$75.16$625,205-73.25%
2023-03-03SaleNovoCure Limited
NVCR
President, CNS Cancers US
5,291
0.0049%
$76.16$402,959-73.53%
2023-03-03SaleNovoCure Limited
NVCR
President, CNS Cancers US
7,350
0.0068%
$76.57$562,818-73.53%
2023-03-03SaleNovoCure Limited
NVCR
President, CNS Cancers US
2,059
0.0019%
$77.64$159,859-73.53%
2023-03-02SaleNovoCure Limited
NVCR
President, CNS Cancers US
844
0.0008%
$75.28$63,535-71.96%
2023-03-02SaleNovoCure Limited
NVCR
President, CNS Cancers US
4,951
0.0047%
$75.36$373,112-71.96%
2023-03-01SaleNovoCure Limited
NVCR
President, CNS Cancers US
1,684
0.0016%
$76.36$128,594-71.92%
2023-01-05SaleNovoCure Limited
NVCR
President, CNS Cancers US
10,471
0.0099%
$119.05$1.25M-65.87%
2022-10-13SaleNovoCure Limited
NVCR
President, CNS Cancers US
6,754
0.0063%
$76.01$513,372-14.77%
2022-10-06SaleNovoCure Limited
NVCR
President, CNS Cancers US
6,754
0.0064%
$84.37$569,835-20.94%
2022-09-29SaleNovoCure Limited
NVCR
President, CNS Cancers US
6,754
0.0065%
$77.35$522,422-11.04%
2022-09-22SaleNovoCure Limited
NVCR
President, CNS Cancers US
6,754
0.0066%
$77.00$520,058-6.58%
2022-09-15SaleNovoCure Limited
NVCR
Chief Development Officer
12,271
0.0116%
$88.52$1.09M-20.68%
2022-09-09SaleNovoCure Limited
NVCR
Chief Development Officer
1,863
0.0018%
$88.00$163,944-20%
2022-09-08SaleNovoCure Limited
NVCR
Chief Development Officer
6,754
0.006%
$81.48$550,316-18.08%
2022-09-06SaleNovoCure Limited
NVCR
Chief Development Officer
1,384
0.0013%
$78.57$108,741-9.88%
2022-09-01SaleNovoCure Limited
NVCR
Chief Development Officer
1,750
0.0016%
$76.96$134,677-9%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.